Recent advances have defined risk factors for orthopaedic implant infections that suggest modifications in the clinical care of certain patients. For diagnosis, new work shows the importance of obtaining multiple specimens for culture, and the enlarging spectrum of causative organisms. The potential for the polymerase chain reaction is demonstrated. In treatment, the value of rifampicin is shown in controlled and open trials.